Pascal and Francis Bibliographic Databases


Search results

Your search

au.\*:("MARBURY T")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 28

  • Page / 2

Selection :

  • and


CHRONIC RENAL VEIN THROMBOSIS.CADE R; SPOONER G; JUNCOS L et al.1977; AMER. J. MED.; U.S.A.; DA. 1977; VOL. 63; NO 3; PP. 387-397; BIBL. 42 REF.Article

An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairmentPETERSON, L; MARBURY, T; MARIER, J et al.Journal of clinical pharmacy and therapeutics (Print). 2013, Vol 38, Num 6, pp 518-523, issn 0269-4727, 6 p.Article

Drug therapy in patients undergoing haemodialysis: clinical pharmacokinetic considerationsLEE, C.-S. C; MARBURY, T. C.Clinical pharmacokinetics. 1984, Vol 9, Num 1, pp 42-66, issn 0312-5963Article

Quadriceps tendon ruptures in uremiaBHOLE, R; FLYNN, J. C; MARBURY, T. C et al.Clinical orthopaedics and related research. 1985, Num 195, pp 200-206, issn 0009-921XArticle

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertensionCHARYSANT, S. G; MARBURY, T. C; ROBINSON, T. D et al.Journal of human hypertension. 2003, Vol 17, Num 6, pp 425-432, issn 0950-9240, 8 p.Article

Repaglinide versus glyburide : a one-year comparison trialMARBURY, T; HUANG, W.-C; STRANGE, P et al.Diabetes research and clinical practice. 1999, Vol 43, Num 3, pp 155-166, issn 0168-8227Article

Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to androgelMARBURY, T; HAMILL, E; BACHAND, R et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 3, pp 115-120, issn 0142-2782, 6 p.Article

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patientsDAMSBO, P; CLAUSON, P; MARBURY, T. C et al.Diabetes care. 1999, Vol 22, Num 5, pp 789-794, issn 0149-5992Article

Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysisLEE, C. C; PETERSON, J. C; MARBURY, T. C et al.Journal of clinical pharmacology. 1983, Vol 23, Num 7, pp 274-280, issn 0091-2700Article

Flexible prandial glucose regulation with repaglinide in patients with Type 2 diabetesDAMSBO, P; MARBURY, T. C; HATORP, V et al.Diabetes research and clinical practice. 1999, Vol 45, Num 1, pp 31-39, issn 0168-8227Article

Long-term safety and antihypertensive efficacy of irbesartan : Pooled results of five open-label studiesLITTLEJOHN, T. III; SAINI, R; KASSLER-TAUB, K et al.Clinical and experimental hypertension (1993). 1999, Vol 21, Num 8, pp 1273-1295, issn 1064-1963Article

Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertensionKARCH, F. E; PORDY, R; BENZ, J. R et al.Clinical therapeutics. 1997, Vol 19, Num 6, pp 1368-1378, issn 0149-2918Conference Paper

Pharmacokinetics of repaglinide in subjects with renal impairmentMARBURY, T. C; RUCKLE, J. L; HATORP, V et al.Clinical pharmacology and therapeutics. 2000, Vol 67, Num 1, pp 7-15, issn 0009-9236Article

Pharmacokinetics of sparfloxacin in patients with renal impairmentDORR, M. B; JOHNSON, R. D; JENSEN, B et al.Clinical therapeutics. 1999, Vol 21, Num 7, pp 1202-1215, issn 0149-2918Article

A Pilot Study to Examine the Feasibility of Insulin Glargine in Subjects with Impaired Fasting Glucose, Impaired Glucose Tolerance or New-Onset Type 2 DiabetesMARBURY, T. C; SCHWARTZ, S; ROSENBERG, M. A et al.Experimental and clinical endocrinology & diabetes. 2008, Vol 116, Num 5, pp 282-288, issn 0947-7349, 7 p.Article

Evaluation of enalapril combined with diltiazem ER in patients with Stage 3-4 essential hypertensionGAVRAS, H; CHRYSANT, S. G; NIEDERMAN, A. L et al.Clinical and experimental hypertension (1993). 1998, Vol 20, Num 1, pp 41-52, issn 1064-1963Article

Effects and tolerability of irbesartan versus enalapril in patients with severe hypertensionLAROCHELLE, P; FLACK, J. M; MARBURY, T. C et al.The American journal of cardiology. 1997, Vol 80, Num 12, pp 1613-1615, issn 0002-9149Article

A placebo-controlled, dose-response study of dexfenfluramine in the treatment of obese patientsMARBURY, T. C; ANGELO, J. E; GULLEY, R. M et al.Current therapeutic research. 1996, Vol 57, Num 9, pp 663-674, issn 0011-393XArticle

Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertensionCHRYSANT, S. G; GAVRAS, H; NIEDERMAN, A. L et al.Journal of clinical pharmacology. 1997, Vol 37, Num 9, pp 810-815, issn 0091-2700Conference Paper

Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adultsMAZZU, A. L; LETTIERI, J. T; KELLY, E et al.European journal of clinical pharmacology. 2000, Vol 56, Num 1, pp 69-74, issn 0031-6970Article

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, Irbesartan and LosartanOPARIL, S; GUTHRIE, R; LEWIN, A. J et al.Clinical therapeutics. 1998, Vol 20, Num 3, pp 398-409, issn 0149-2918Article

Effectiveness of indapamide versus enalapril as second-step therapy of systemic hypertensionAMES, R; GRIFFING, G; MARBURY, T et al.The American journal of cardiology. 1992, Vol 69, Num 3, pp 267-270, issn 0002-9149Article

Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertensionCUSHMAN, W. C; COHEN, J. D; JONES, R. P et al.American journal of hypertension. 1998, Vol 11, Num 1, pp 23-30, issn 0895-7061, 1Article

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis CBRENNAN, B. J; MORCOS, P. N; WANG, K et al.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 10, pp 1209-1220, issn 0269-2813, 12 p.Article

  • Page / 2